Corline Biomedical AB (STO:CLBIO)

Corline Biomedical AB Revenue

Corline Biomedical AB had revenue of 4.31M SEK in the quarter ending March 31, 2026, with 93.14% growth. This brings the company's revenue in the last twelve months to 10.70M, down -25.06% year-over-year. In the year 2025, Corline Biomedical AB had annual revenue of 8.62M, down -51.27%.

• Revenue (ttm): 10.70M
• Revenue Growth: -25.06%
• P/S Ratio: 43.00
• Revenue / Employee: 820.46K
• Employees: 13
• Market Cap: 458.64M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	8.62M	-9.07M	-51.27%
Dec 31, 2024	17.69M	-18.25M	-50.78%
Dec 31, 2023	35.93M	2.60M	7.80%
Dec 31, 2022	33.33M	16.07M	93.09%
Dec 31, 2021	17.26M	2.16M	14.29%
Dec 31, 2020	15.10M	3.15M	26.36%
Dec 31, 2019	11.95M	2.42M	25.35%
Dec 31, 2018	9.54M	-6.62M	-40.98%
Dec 31, 2017	16.16M	5.79M	55.87%
Dec 31, 2016	10.37M	6.86M	195.50%
Dec 31, 2015	3.51M	-140.83K	-3.86%
Dec 31, 2014	3.65M	-614.17K	-14.41%
Dec 31, 2013	4.26M	-	-

Data Source: Fiscal.ai Last updated: May 8, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 23, 2026

Data Sources Report a data error